DrugPatentWatch Database Preview

ZAGAM Drug Profile

« Back to Dashboard

When do Zagam patents expire, and when can generic versions of Zagam launch?

Zagam is a drug marketed by Mylan and is included in one NDA.

The generic ingredient in ZAGAM is sparfloxacin. Additional details are available on the sparfloxacin profile page.

Summary for ZAGAM

US Patents:	0
Applicants:	1
NDAs:	1
Bulk Api Vendors:	60
Patent Applications:	3,425
Formulation / Manufacturing:	see details
Drug Prices:	see details
DailyMed Link:	ZAGAM at DailyMed

Synonyms for ZAGAM

(cis)-5-amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

110871-86-8

111542-93-9

3-Quinolinecarboxylic acid, 1,4-dihydro-5-amino-1-cyclopropyl-6,8-difluoro-7-(3,5-dimethyl-1-piperazinyl)-4-oxo-, cis-

3-Quinolinecarboxylic acid, 5-amino-1-cyclopropyl-7-((3R,5S)-3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-, rel-

3-Quinolinecarboxylic acid, 5-amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-, cis-

3-Quinolinecarboxylic acid, 5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-6,8-difluoro-1,4-dihydro-4-oxo-, rel-

5-Amino-1-cyclohexyl-7-(cis-3,5-dimethylpiperazino)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

5-amino-1-cyclopropyl-6,8-difluoro-7-(cis-3,5-dimethyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid

5-amino-1-cyclopropyl-7-((3R,5S)-3,5-dimethylpiperazin-1-yl)-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

5-amino-1-cyclopropyl-7-((3S,5R)-3,5-dimethylpiperazin-1-yl)-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)- 6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid

5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl)-6,8- difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid & RU 40555

5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid & RU 40555

5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxo-quinoline-3-carboxylic acid

5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxoquinoline-3-carboxylic acid

5-amino-1-cyclopropyl-7-[(3S,5R)-3,5-dimethyl-1-piperazinyl]-6,8-difluoro-4-oxo-3-quinolinecarboxylic acid

5-amino-1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxo-quinoline-3-carboxylic acid

5-amino-1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxoquinoline-3-carboxylic acid

5-azanyl-1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-6,8-bis(fluoranyl)-4-oxidanylidene-quinoline-3-carboxylic acid

871S868

A802376

AB00639950_03

AB00639950-02

AC-11574

AC1L1TB5

AC1Q29E9

AJ-23393

AK115680

AKOS005622503

AN-33527

API0004214

AT 4140

AT-4140

AX8151779

BB_SC-1127

BBL010957

BDBM50366822

BRN 3658018

C07662

CAS-110871-86-8

CCG-221166

CHEBI:9212

CHEMBL850

CI 978

CI-978

cis-5-Amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

CP 103826

CP-103826

CPD000466312

CS-2347

D00590

D0K6GZ

DB01208

DRG-0143

DSSTox_CID_3590

DSSTox_GSID_23590

DSSTox_RID_77097

DTXSID9023590

DZZWHBIBMUVIIW-DTORHVGOSA-N

Epitope ID:119065

Esparfloxacino

Esparfloxacino [INN-Spanish]

FT-0631055

FT-0674635

HE066359

HE295402

HMS2090N19

HY-B0308

I06-1320

KB-291851

KS-5009

Liposome-encapsulated sparfloxacin

LS-141521

MCULE-1827276157

MFCD00869619

MLS000759417

MolPort-002-507-759

NCGC00159333-02

NCGC00166294-01

NCGC00166294-02

NCGC00166294-03

Parox

PD 1315-1

PD 131501

PD-131501

PD131501

Q90AGA787L

Respipac (TN)

RP-64206

RT-015760

S0896

s1884

SAM001246566

SC-96745

SCHEMBL41311

SMR000466312

Spara

sparcin

sparfloxacin

Sparfloxacin (JAN/USAN/INN)

Sparfloxacin [USAN:BAN:INN:JAN]

Sparfloxacin [USAN:INN:BAN:JAN]

Sparfloxacin & RU 40555

Sparfloxacin trihydrate

Sparfloxacin, >=98.0% (HPLC)

Sparfloxacin, Antibiotic for Culture Media Use Only

sparfloxacin, cis-isomer

Sparfloxacin, VETRANAL(TM), analytical standard

Sparfloxacine

Sparfloxacine [INN-French]

Sparfloxacinum

Sparfloxacinum [INN-Latin]

SPFX

SR-01000759357

SR-01000759357-2

ST24031663

STK802067

Tox21_111580

Tox21_111580_1

UNII-Q90AGA787L

Zagam (TN)

ZINC538362

US Patents and Regulatory Information for ZAGAM

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan	ZAGAM	sparfloxacin	TABLET;ORAL	020677-001	Dec 19, 1996		DISCN	No	No

Expired US Patents for ZAGAM

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mylan	ZAGAM	sparfloxacin	TABLET;ORAL	020677-001	Dec 19, 1996